Jointown Pharmaceutical announces share pledge adjustments by controlling shareholder

Jointown Pharmaceutical Group Co., Ltd. announced that its controlling shareholder, Chuchang Investment, completed the early release of 13m shares, representing 0.26% of the company's total share capital. Concurrently, Zhongshan Guangyin, a related party, pledged 13.5m shares, accounting for 0.27% of the total share capital, to Hankou Bank Hanyang Branch. These transactions were completed on November 7, 2025, and November 6, 2025, respectively.

Following these adjustments, Chuchang Investment and Zhongshan Guangyin collectively hold 459.5m shares and 335.3m shares, representing 9.11% and 6.65% of Jointown Pharmaceutical Group's total share capital. The total pledged shares for Chuchang Investment now stand at 249.8m shares (54.37% of its holdings), and for Zhongshan Guangyin at 249.6m shares (74.46% of its holdings).

As of November 6, 2025, the controlling shareholder and parties acting in concert hold 2.29bn shares, or 45.43% of the company's total share capital. The aggregate number of pledged shares for these entities is 1.07bn, which constitutes 47.03% of their total holdings and 21.37% of the company's total share capital. The company affirmed that the controlling shareholder and its concerted parties have the financial capacity for repayment, sourced from bond issuance, dividends, and investment income, without any negative impact on operations.